{"contentid": 488005, "importid": NaN, "name": "Pricing and regulatory challenges impact revenue, new study reveals", "introduction": "Cloud revenue management solutions provider Model N has announced findings from its 2021 State of Revenue Report, which examines current issues around revenue execution and management in the healthcare sector.", "content": "<p>Cloud revenue management solutions provider Model N (NYSE: MODN) has announced findings from its <a href=\"http://www.modeln.com/stateofrevenue2021\">2021 State of Revenue Report</a>, which examines current issues around revenue execution and management in the healthcare sector.&nbsp;</p>\n<p>Among its main findings:</p>\n<p>98% of executives from pharma companies, medical device manufacturers and biotech firms think that regulatory compliance results in revenue loss, according to the newly released report.</p>\n<p>The life sciences industry operates in a complex regulatory landscape that precipitates numerous pricing challenges, and:</p>\n<ul>\n<li>98% of executives think that regulatory compliance results in revenue loss; and</li>\n<li>Some 91% are concerned that regulations will have a greater impact in 2021, while 57% say they are &ldquo;very concerned&rdquo; about the impact of additional compliance regulations, a dramatic increase from 33% in 2020.</li>\n</ul>\n<p>Additionally, more than half of life sciences firms report they face volatile pricing and market demands, as well as customer demands for greater price transparency, and that they must more effectively manage global pricing and rebates, incentives and chargebacks.&nbsp;</p>\n<ul>\n<li>Around half of the respondents (51%) said that managing global pricing is a challenge, and 35% report that pricing conflicts became worse in the past year, up from 19% in 2020.</li>\n<li>More than half (57%) said their company has adopted value-based contracting in the past two years.</li>\n</ul>\n<p>According to Melonie Warfel, vice president and general manager of life sciences for Model N, the survey findings reflect both the acute need for revenue management and the industry&rsquo;s readiness to embrace technology-enabled solutions.</p>\n<p>&ldquo;Our customers are constantly balancing changes to existing regulations, preparing for new requirements, and simultaneously maintaining ambitious research and development efforts,&rdquo; she said.</p>\n<p>&ldquo;More companies are leveraging AI-powered platforms like Model N&rsquo;s revenue cloud to ensure regulatory compliance and manage revenues, which helps to support innovation. Having the technology to respond quickly to unrelenting pricing pressure in a changing environment is absolutely essential,&rdquo; she claimed.</p>", "date": "2021-03-11 10:11:00", "meta_title": "Pricing and regulatory challenges impact revenue, new study reveals", "meta_keywords": "Pricing, Regulations, Challenges, Revenues, Model N", "meta_description": "Pricing and regulatory challenges impact revenue, new study reveals", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-10 18:34:12", "updated": "2021-03-11 10:11:33", "access": NaN, "url": "https://www.thepharmaletter.com/article/pricing-and-regulatory-challenges-impact-revenue-new-study-reveals", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "marketreportbig.jpg", "image2id": "marketreportsmall.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "All therapy areas", "topic_tag": "Financial, Management, Pricing, reimbursement and access, Regulation", "geography_tag": "Global", "company_tag": "MODEL N&#44;&nbsp; INC.", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-11 10:11:00"}